5-LOX-IN-2
5-LOX-IN-2, an inhibitor of 5-lipoxygenase (5-LOX) with an IC50 of 0.33 μM, inhibits 5-LOX in a dose-dependent manner . 5-LOX-IN-2, reduces the cell viability of renal cancer cells and induces apoptosis, can be used for cancer research[1].
Product Specifications
CAS Number
[179691-97-5]
UNSPSC
12352005
Target
Lipoxygenase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/5-lox-in-2.html
Purity
98.75
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(OCCC1=CC=CC=C1)/C=C/C2=CC(O)=CC=C2O
Molecular Formula
C17H16O4
Molecular Weight
284.31
References & Citations
[1]Selka A, et.al. Discovery of a novel 2,5-dihydroxycinnamic acid-based 5-lipoxygenase inhibitor that induces apoptosis and may impair autophagic flux in RCC4 renal cancer cells. Eur J Med Chem. 2019 Oct 1;179:347-357.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
5-LOX
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15335181 1 Vial
Lentiviral human CMPK2 shRNA (UAS) - Lentiviral human CMPK2 shRNA (UAS) (100)
Sign In for Pricing
View Details 
MBS6457151-01 0.2 mL
MCM9 (DNA Helicase MCM9, hMCM9, Mini-Chromosome maintenance deficient Domain-Containing Protein 1, MiniChromosome maintenance 9, MCM9, C6orf61, MCMDC1) (PE)
Sign In for Pricing
View Details MBS6457151-02 5x 0.2 mL
MCM9 (DNA Helicase MCM9, hMCM9, Mini-Chromosome maintenance deficient Domain-Containing Protein 1, MiniChromosome maintenance 9, MCM9, C6orf61, MCMDC1) (PE)
Sign In for Pricing
View Details 
K1958302 1.0 µg DNA
RPL29P32 sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details